With widespread abuse of antibiotics, bacterial resistance has increasingly become a serious threat. Acinetobacter baumannii has emerged as one of the most important hospital-acquired pathogens worldwide. Bacteriophages (also called “phages”) could be used as a potential alternative therapy to meet the challenges posed by such pathogens. Endolysins from phages have also been attracting increasing interest as potential antimicrobial agents. Here, we isolated 14 phages against A. baumannii, determined the lytic spectrum of each phage, and selected one with a relatively broad host range, named vB_AbaP_PD-6A3 (PD-6A3 for short), for its biological characteristics. We over-expressed and purified the endolysin (Ply6A3) from this phage and tested its biological characteristics. The PD-6A3 is a novel phage, which can kill 32.4% (179/552) of clinical multidrug resistant A. baumannii (MDRAB) isolates. Interestingly, in vitro, this endolysin could not only inhibit A. baumannii, but also that of other strains, such as Escherichia coli and methicillin-resistant Staphylococcus aureus (MRSA). We found that lethal A. baumannii sepsis mice could be effectively rescued in vivo by phage PD-6A3 and endolysin Ply6A3 intraperitoneal injection. These characteristics reveal the promising potential of phage PD-6A3 and endolysin Ply6A3 as attractive candidates for the control of A. baumannii-associated nosocomial infections.
Preceramic polymers offer exceptional potential for low-temperature processing of both oxide and non-oxide ceramics. In addition, shapes such as fibers, films, and membranes that are not commonly available using standard processing techniques are readily available using preceramic polymers. In non-oxide ceramics, the ceramic products generally available from preceramics do not exhibit all of the typical properties associated with the same materials produced by standard, high-temperature processing approaches. In part, this appears to be because there are very few preceramic polymers that lead to high-purity, singlephase materials. Poly(methylsilane), (-[MeHSi],-), produced from MeSiH3, can be used to produce relatively pure, bulk Sic at temperatures below 1000°C. The transformation process from polymer to ceramic is followed by 29Si NMR and diffuse reflectance IR. The polymer first undergoes a major rearrangement from poly(si1ane) to poly(carbosi1ane) at 400°C. Above 400"C, the resulting poly(carbosi1ane) decomposes to a hydrogenated form of Sic as shown by spectroscopic analysis of the 600°C material. Further heating, to 1000°C for 1 h, provides very narrow 29Si peaks indicative of B-Sic mixed with small amounts of a-Sic polytypes. Chemical analysis, when coupled with the 29Si and XRD results, suggests that poly(methylsi1ane) produces resonably pure, nanocrystalline Sic at temperatures much lower than previously observed for other Sic preceramic polymers. [
Carbon spheres (CS)@MnO2 core-shell nanocomposites, with MnO2 nanoflakes uniformly coating at the surface of CS cores, were successfully synthesized by a facile water-bathing method. MnO2 amounts is estimated to be 24.7 wt% in CS@MnO2 nanocomposites. A high dielectric loss value and an electromagnetic shielding effectiveness of 16‒23 dB were observed for the CS@MnO2 in the frequency range of 8‒18 GHz, which is mainly attributed to the enhanced absorption loss. The incorporation of the CS with MnO2 improves the electrical conductivity. Meanwhile, the electromagnetic impendence matching has been significantly ameliorated. Moreover, the increasing interfaces between the CS and MnO2 facilitate the microwave attenuation as well. Thus, the electromagnetic shielding performances were greatly enhanced. Our findings provide an effective methodology for the synthesis of the CS@MnO2 core-shell nanocomposite for potential electromagnetic applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.